Mayor Bill de Blasio recently visited the lab of Dr. Brent Stockwell to discuss the new Columbia NYC Therapeutic Validation Center. The city is investing up to $9 million in the Center to help establish research facilities aimed at turning early-stage research into new start-ups as part of a wider effort to transform New York City into the “public health capital of the world.”
The Columbia NYC Therapeutic Validation Center will use mass spectrometry imaging technology “to create next-generation medicines that work by analyzing and orchestrating the behavior of individual cells in the human body to work in concert to eliminate disease.”
Mayor DeBlasio toured the lab with Rachel Loeb, President of New York City Economic Development Corp (NYCEDC), Carlo Yuvienco, Vice President for Life Science at NYCEDC, and Dr. Hynek Wichterle, a collaborator with whom Dr. Stockwell is developing a small molecule treatment for ALS, among others.
“I was surprised that he knew I grew up in Queens!” said Dr. Stockwell, who was recently listed on The Life Sciences Power 50, a list of 50 scientists, entrepreneurs and investors driving NYC’s biotech boom. “I was also impressed by how much he wanted to talk about the details of the science.” He says it was clear during the visit that Mayor de Blasio is committed to building life sciences in New York City and making the city a world-leading biotech hub.